Innovative therapeutic solutions for patients begin here


  • Sanofi and the University of Bordeaux collaborate on Muscle Wasting Diseases in Frail Elderly


Home Right Content

  • Introducing the Open Innovation Access Platform


    The Sanofi Open Innovation Access Platform (OIAP) aims to create a permeable research environment to accelerate the transformation of scientific innovation into therapeutic projects. We are located in Strasbourg, in the regional ecosystem of the upper Rhine Biovalley, one of the leading life science cluster in Europe.
    The mission of the OIAP is an integral part of Sanofi’s R&D strategy of partnership in pharmaceutical innovation. Our center has put in place a collaborative model based on sharing risks and benefits with academic or biotech partners.
    With the support of all Sanofi R&D therapeutic areas , we offer to our partners the opportunity to move their basic research discoveries towards clinical applications.